Status:
ACTIVE_NOT_RECRUITING
RUDRA Registry (Real-World Clinical Registry for Patients With Recurrent Pericarditis)
Lead Sponsor:
Eurasian Association of Therapists
Conditions:
Pericarditis
Eligibility:
All Genders
18+ years
Brief Summary
А multicenter, non-interventional real world clinical registry of patients with recurrent pericarditis. The main goal of the registry is to epidemiologically assess the pattern, clinical outcomes, an...
Detailed Description
А multicenter, non-interventional real world clinical registry of patients with recurrent pericarditis. The main goal of the registry is to epidemiologically assess the pattern, clinical outcomes, an...
Eligibility Criteria
Inclusion
- Men or women 18 years of age or older at the time of data recording or pericarditis debut;
- Presence of one of the following conditions:
- a specialist-confirmed diagnosis of recurrent pericarditis without an established etiology at the time of inclusion in the study (suspected "idiopathic recurrent pericarditis");
- a specialist-confirmed diagnosis of "idiopathic recurrent pericarditis".
Exclusion
- Age below 18 years at the time of inclusion in the registry or debut of pericarditis;
- Specialist-confirmed secondary genesis of RP (infectious, autoimmune, neoplastic, metabolic, traumatic, iatrogenic, etc.); 2. Manifestations and complications of myocarditis, various diseases of thoracic organs, systemic diseases, cardiac surgery, radiation therapy, tuberculosis, etc.);
- lack of possibility of screening examination and dynamic follow-up;
- Organ/tissue transplantation less than 5 years prior to study inclusion or debut of pericarditis;
- Oncologic disease less than 3 years prior to study inclusion or pericarditis debut;
- Chemotherapy with anthracycline-type drugs at the time of pericarditis debut;
- Administration of amphetamine-type drugs at the time of pericarditis debut;
- Cardiac/pericardial surgery in the last 6 months prior to study inclusion or pericarditis debut;
- Myocardial infarction in the last 3 months prior to study inclusion or debut of pericarditis;
- Traumatic chest injury in the last 3 months prior to study inclusion or pericarditis debut;
- Absence of an informed consent form signed by the patient for participation in the study
Key Trial Info
Start Date :
September 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06517966
Start Date
September 30 2024
End Date
November 1 2028
Last Update
August 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eurasian Association of Therapists
Moscow, Russia, 11000